15-12G - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

POSASR - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)

25-NSE - Bruker Cellular Analysis, Inc. (0001689657) (Subject)

8-K - PhenomeX Inc. (0001689657) (Filer)

SC TO-T/A - PhenomeX Inc. (0001689657) (Subject)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)

Contineum Therapeutics, Inc. (NASDAQ:CTNM), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Sarah Boyce, President and Chief Executive Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), as an independent member of its Board of Directors. Ms. Boyce brings over 25 years of global commercial and clinical development expertise in the life sciences industry to Contineum's board. Ms. Boyce has extensive expertise in global pharmaceut

PhenomeX to begin trading under symbol (NASDAQ:CELL) EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol "CELL" at market open tomorrow. PhenomeX is positioned to be the leading

EMERYVILLE, Calif., Feb. 23, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Highlights Achieved revenue of $78.6 million for the full year 2022, representing an 8% decrease over the prior year;Announced the acquisition agreement of IsoPlexis to create a premier functional cell biology company, PhenomeX, when the merger closes, would accelerate the transformation of Berkeley Lights from a technology platform company into a growing, profi

EMERYVILLE, Calif., Feb. 13, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   Live audio of the webcast will be available on the "Investors" section of the Company's website at www.berkeleylights.com. The webcast will be archived and available for replay

EMERYVILLE, Calif., Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended December 31, 2022. Total revenue for the full year 2022 is expected to be in the range of $78.0 million to $78.5 million, compared to $85.4 million in 2021. Results were lower-than-expected due to a delay in several Beacon® platform placements, which are now expected in 2023, and lower revenue from partnership and services contracts. During fourth quarter 2022, we observed a tightening

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications EMERYVILLE, Calif., Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development (CLD). The Beacon Select builds upon the same cutting-edge technology offered by the original Beacon system launched in 2017 that currently has an installed base of more than 130 systems globally. The Beacon Select offers customers optofluidic and NanoPen® chamber technol

EMERYVILLE, Calif., Jan. 3, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Berkeley Lights management is scheduled to present and participate in a Q&A session on Thursday, January 12 at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at www.berkeleylights.com. About Berkeley LightsBerkeley Lights i

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET EMERYVILLE, CA and BRANFORD, Conn., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights (NASDAQ:BLI), a life sciences tools company, and IsoPlexis (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET EMERYVILLE, Calif. and BRANFORD, Conn., Dec. 21, 2022 /PRNewswire/ -- Berkeley Lights (NASDAQ:BLI), a life sciences tools company, and IsoPlexis (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoP

EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Therapeutics (AE&T) meeting, being held from December 4 - 8, 2022, in San Diego, California. During the AE&T meeting, the latest antibody science, technologies, and academic and industry partners come together to accelerate next-generation antibodies towards commercial success. Berkeley Lights will showcase its Beacon® Optofluidic System and single B-cell antibody discovery workflows at

SC 13G/A - Bruker Cellular Analysis, Inc. (0001689657) (Subject)

SC 13G - PhenomeX Inc. (0001689657) (Subject)

SC 13G/A - PhenomeX Inc. (0001689657) (Subject)

SC 13G - PhenomeX Inc. (0001689657) (Subject)

SC 13G - Berkeley Lights, Inc. (0001689657) (Subject)

SC 13G/A - Berkeley Lights, Inc. (0001689657) (Subject)

SC 13G/A - Berkeley Lights, Inc. (0001689657) (Subject)

SC 13G - Berkeley Lights, Inc. (0001689657) (Subject)

SC 13G/A - Berkeley Lights, Inc. (0001689657) (Subject)

SC 13G/A - Berkeley Lights, Inc. (0001689657) (Subject)

  On Tuesday, 74 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: First Majestic Silver (NYSE:AG) was the biggest company in terms of market cap to set a new 52-week low. The smallest company by market cap to hit a new 52-week low was Dunxin Financial Hldgs (AMEX:DXF). Qutoutiao (NASDAQ:QTT) made the largest move down on the session, with shares plummeting 57.39% to reach its 52-week low. Angel Oak Financial (NYSE:FINS)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low. The stocks that set new 52-week lows on Tuesday: First Majestic Silver (NYSE:AG) stock dropped to a yearly low on Tuesday of $5.56. Shares

  On Wednesday, 116 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was CVS Health (NYSE:CVS). The smallest company by market cap to set a new 52-week low was Altamira Therapeutics (NASDAQ:CYTO). Intelligent Bio Solutions (NASDAQ:INBS)'s stock moved significantly downwards, trading down 46.21% to reach a new 52-week low. Independent Bank Gr (NASDAQ:IBTX)'s stock made the biggest bounce back, actually moving up 0.0% shortly after hitting a new 52-week low. Here are all the stocks that set new 52-week lows on Wednesday: CVS Health (NYSE:CVS) shares hit a yearly low of $80.10. The stock was do

  On Tuesday, 93 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Sirius XM Holdings (NASDAQ:SIRI) was the largest company by market cap to set a new 52-week low. The company with the smallest market cap to set a new 52-week low was Altamira Therapeutics (NASDAQ:CYTO). Cara Therapeutics (NASDAQ:CARA)'s stock fell the most, as it traded down 31.35% to reach a new 52-week low. Vintage Wine Estates (NASDAQ:VWE) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low. Here are all the stocks that set new 52-week lows on Tuesday: Sirius XM Holdings (NASDAQ:SIRI) shares were down 4.3% for the day, having made a

Berkeley Lights (NASDAQ:BLI) brought in sales totaling $17.84 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 35.87%, resulting in a loss of $29.30 million. Berkeley Lights collected $21.40 million in revenue during Q3, but reported earnings showed a $21.57 million loss. Why Is ROCE Significant? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q

  On Friday, 135 companies reached new 52-week lows. Facts of Interest About Today's 52-Week Lows: Johnson & Johnson (NYSE:JNJ) was the largest company by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was Grom Social Enterprises (NASDAQ:GROM). Windtree Therapeutics (NASDAQ:WINT)'s stock made the biggest move downwards, diving 4296.46% to reach a new 52-week low. CI&T (NYSE:CINT)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low. On Friday, the following stocks broke to new 52-week lows: Johnson & Johnson (NYSE:JNJ) stock drifted down 1.41% on Friday morning to hit a new 52-week low of

Berkeley Lights (NASDAQ:BLI) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 57.69 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $17.84 million which missed the analyst consensus estimate of $24.60 million by 27.48 percent. This is a 23.05 percent decrease over sales of $23.19 million the same period last year.

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. • Calliditas Therapeutics (NASDAQ:CALT) is estimated to report quarterly loss at $0.57 per share on revenue of $18.93 million. • Gold Fields (NYSE:GFI) is estimated to report earnings for its Fiscal Year 2022. • Teekay (NYSE:TK) is projected to report earnings for its fourth quarter. • Teekay Tankers (NYSE:TNK) is projected to report quarterly earnings at $3.33 per share on revenue of $198.85 million. • Modiv (NYSE:MDV) is projected to report quarterly loss at $0.11 per share on revenue of $10.45 million. • Medical Properties Trust (NYSE:MPW) is estimated to re

-Reutesr

-SEC Filing

  During Tuesday, 40 stocks hit new 52-week lows. Significant Points From Today's 52-Week Lows: Sirius XM Holdings (NASDAQ:SIRI) was the biggest company by market cap to set a new 52-week low. Revelation Biosciences (NASDAQ:REVB) was the smallest company by market cap to set a new 52-week low. TOP Ships (NASDAQ:TOPS) shares traded down 43.04% to reach its 52-week low, making it the biggest loser. Kenon Hldgs (NYSE:KEN) shares actually gained 0.2%, rebounding after it reached its 52-week low. The following stocks achieved new 52-week lows on Tuesday: Sirius XM Holdings (NASDAQ:SIRI) shares reached a new 52-week low of $4.64 on Tuesday morning, moving down 0.53%. Braskem (NYSE:BA